CLINICAL STUDY ON CARFECILLIN IN URINARY TRACT INFECTION

1) The sensitivity distribution of E. coli isolated clinically was 6.25-100 μg/ml for carfecillin. 2) Thirteen cases of acute simple, 2 cases of complicated and 5 cases of chronic complicated urinary tract infections were treated with carfecillin. 3) Acute urinary tract infections were treated with...

Full description

Saved in:
Bibliographic Details
Published inCHEMOTHERAPY Vol. 23; no. 7; pp. 2371 - 2376
Main Authors IKI, YOSHIO, OGAWA, HIDEYA
Format Journal Article
LanguageJapanese
Published Japanese Society of Chemotherapy 1975
Online AccessGet full text

Cover

Loading…
More Information
Summary:1) The sensitivity distribution of E. coli isolated clinically was 6.25-100 μg/ml for carfecillin. 2) Thirteen cases of acute simple, 2 cases of complicated and 5 cases of chronic complicated urinary tract infections were treated with carfecillin. 3) Acute urinary tract infections were treated with daily administration of 1-3 g of carfecillin f or 3-7 days. Chronic urinary tract infections were treated with daily administration of 1-3 g of carfecillin for 7-14 days. 4) Of 15 cases with acute urinary tract infections, excellent response was seen in 10 cases, and of 5 cases with chronic urinary tract infections, satisfactory bacteriological response was seen in 4 cases. 5) No side effects were observed except one case in which diarrhea was noticed. 6) No abnormal findings were revealed in peripheral blood, kidney (BUN) and liver function test.
ISSN:0009-3165
1884-5894
DOI:10.11250/chemotherapy1953.23.2371